How Research Directly Improves Patient Treatment
Brustkrebszentrum Paderborn is pioneering precision oncology in Germany, offering patients access to cutting-edge therapies—including PARP inhibitors and novel antibody-drug conjugates—directly through clinical trials. As of this week, the center reports ... Read More